{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:11:45Z","timestamp":1792289505730,"version":"4.4.0"},"reference-count":263,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41569-020-00469-1","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T07:04:30Z","timestamp":1605769470000},"page":"194-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":370,"title":["Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation"],"prefix":"10.1038","volume":"18","author":[{"given":"Sean X.","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian W.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Hwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane S.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred I.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Halene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3508-2678","authenticated-orcid":false,"given":"Hyung J.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7366-2628","authenticated-orcid":false,"given":"John","family":"Hwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"469_CR1","unstructured":"Johns Hopkins Coronavirus Resource Center. COVID-19 Dashboard. https:\/\/coronavirus.jhu.edu\/map.html (2020)."},{"key":"469_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727\u2013733 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang, C., Horby, P. W., Hayden, F. G. & Gao, G. F. A novel coronavirus outbreak of global health concern. Lancet 395, 470\u2013473 (2020).","journal-title":"Lancet"},{"key":"469_CR4","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(20)30557-2","volume":"395","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet 395, 949\u2013950 (2020).","journal-title":"Lancet"},{"key":"469_CR5","doi-asserted-by":"publisher","first-page":"S223","DOI":"10.1097\/01.inf.0000188166.17324.60","volume":"24","author":"JS Kahn","year":"2005","unstructured":"Kahn, J. S. & McIntosh, K. History and recent advances in coronavirus discovery. Pediatric Infect. Dis. J. 24, S223\u2013S227 (2005).","journal-title":"Pediatric Infect. Dis. J."},{"key":"469_CR6","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa030747","volume":"348","author":"C Drosten","year":"2003","unstructured":"Drosten, C. et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1967\u20131976 (2003).","journal-title":"N. Engl. J. Med."},{"key":"469_CR7","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa030781","volume":"348","author":"TG Ksiazek","year":"2003","unstructured":"Ksiazek, T. G. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953\u20131966 (2003).","journal-title":"N. Engl. J. Med."},{"key":"469_CR8","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","volume":"361","author":"JSM Peiris","year":"2003","unstructured":"Peiris, J. S. M. et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319\u20131325 (2003).","journal-title":"Lancet"},{"key":"469_CR9","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science.1085952","volume":"300","author":"PA Rota","year":"2003","unstructured":"Rota, P. A. et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300, 1394\u20131399 (2003).","journal-title":"Science"},{"key":"469_CR10","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki, A. M., Boheemen, S. V., Bestebroer, T. M., Osterhaus, A. D. M. E. & Fouchier, R. A. M. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814\u20131820 (2012).","journal-title":"N. Engl. J. Med."},{"key":"469_CR11","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMra032498","volume":"349","author":"JSM Peiris","year":"2003","unstructured":"Peiris, J. S. M., Yuen, K. Y., Osterhaus, A. D. M. E. & St\u00f6hr, K. The severe acute respiratory syndrome. N. Engl. J. Med. 349, 2431\u20132441 (2003).","journal-title":"N. Engl. J. Med."},{"key":"469_CR12","unstructured":"World Health Organization. MERS monthly summary Nov 2019. https:\/\/www.who.int\/emergencies\/mers-cov\/en\/ (2020)."},{"key":"469_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","volume":"386","author":"A Zumla","year":"2015","unstructured":"Zumla, A., Hui, D. S. & Perlman, S. Middle East respiratory syndrome. Lancet 386, 995\u20131007 (2015).","journal-title":"Lancet"},{"key":"469_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2018","unstructured":"Cui, J., Li, F. & Shi, Z.-L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17, 181\u2013192 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"469_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565\u2013574 (2020).","journal-title":"Lancet"},{"key":"469_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","volume":"495","author":"VS Raj","year":"2013","unstructured":"Raj, V. S. et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495, 251\u2013254 (2013).","journal-title":"Nature"},{"key":"469_CR17","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba, K. et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11, 875\u2013879 (2005).","journal-title":"Nat. Med."},{"key":"469_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"469_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.e8 (2020).","journal-title":"Cell"},{"key":"469_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","volume":"26","author":"MA Tortorici","year":"2019","unstructured":"Tortorici, M. A. et al. Structural basis for human coronavirus attachment to sialic acid receptors. Nat. Struct. Mol. Biol. 26, 481\u2013489 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"469_CR21","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.3390\/ijms21124549","volume":"21","author":"CH Kim","year":"2020","unstructured":"Kim, C. H. SARS-CoV-2 evolutionary adaptation toward host entry and recognition of receptor O-acetyl sialylation in virus-host interaction. Int. J. Mol. Sci. 21, 4549 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"469_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"469_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507\u2013513 (2020).","journal-title":"Lancet"},{"key":"469_CR24","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061\u20131069 (2020).","journal-title":"JAMA"},{"key":"469_CR25","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu, C. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 180, 934\u2013943 (2020).","journal-title":"JAMA Intern. Med."},{"key":"469_CR27","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054\u20131062 (2020).","journal-title":"Lancet"},{"key":"469_CR28","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/jth.14830","volume":"18","author":"S Cui","year":"2020","unstructured":"Cui, S., Chen, S., Li, X., Liu, S. & Wang, F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 18, 1421\u20131424 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/CIRCULATIONAHA.120.047407","volume":"142","author":"B Ren","year":"2020","unstructured":"Ren, B. et al. Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan. Circulation 142, 181\u2013183 (2020).","journal-title":"Circulation"},{"key":"469_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.120.046702","volume":"142","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: prevalence, risk factors, and outcome. Circulation 142, 114\u2013128 (2020).","journal-title":"Circulation"},{"key":"469_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok, F. A. et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res. 191, 145\u2013147 (2020).","journal-title":"Thromb. Res."},{"key":"469_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok, F. A. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb. Res. 191, 148\u2013150 (2020).","journal-title":"Thromb. Res."},{"key":"469_CR33","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1111\/jth.14888","volume":"18","author":"S Middeldorp","year":"2020","unstructured":"Middeldorp, S. et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J. Thromb. Haemost. 18, 1995\u20132002 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.120.047430","volume":"142","author":"J Poissy","year":"2020","unstructured":"Poissy, J. et al. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation 142, 184\u2013186 (2020).","journal-title":"Circulation"},{"key":"469_CR35","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms, J. et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 46, 1089\u20131098 (2020).","journal-title":"Intensive Care Med."},{"key":"469_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.10478","volume":"3","author":"J Nahum","year":"2020","unstructured":"Nahum, J. et al. Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19). JAMA Netw. Open 3, e2010478 (2020).","journal-title":"JAMA Netw. Open"},{"key":"469_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","volume":"191","author":"C Lodigiani","year":"2020","unstructured":"Lodigiani, C. et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res. 191, 9\u201314 (2020).","journal-title":"Thromb. Res."},{"key":"469_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M20-2003","volume":"173","author":"D Wichmann","year":"2020","unstructured":"Wichmann, D. et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann. Intern. Med. 173, 268\u2013277 (2020).","journal-title":"Ann. Intern. Med."},{"key":"469_CR39","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/jth.14844","volume":"18","author":"M Dolhnikoff","year":"2020","unstructured":"Dolhnikoff, M. et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J. Thromb. Haemost. 18, 1517\u20131519 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR40","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","volume":"20","author":"L Carsana","year":"2020","unstructured":"Carsana, L. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect. Dis. 20, 1135\u20131140 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"469_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/his.14134","volume":"77","author":"T Menter","year":"2020","unstructured":"Menter, T. et al. Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. Histopathology 77, 198\u2013209 (2020).","journal-title":"Histopathology"},{"key":"469_CR42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","volume":"8","author":"SE Fox","year":"2020","unstructured":"Fox, S. E. et al. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir. Med. 8, 681\u2013686 (2020).","journal-title":"Lancet Respir. Med."},{"key":"469_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 383, 120\u2013128 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR44","doi-asserted-by":"publisher","first-page":"100434","DOI":"10.1016\/j.eclinm.2020.100434","volume":"24","author":"V Amy","year":"2020","unstructured":"Amy, V. et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series. EClinicalMedicine 24, 100434 (2020).","journal-title":"EClinicalMedicine"},{"key":"469_CR45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007621","volume":"382","author":"MR Mehra","year":"2020","unstructured":"Mehra, M. R., Desai, S. S., Kuy, S., Henry, T. D. & Patel, A. N. Cardiovascular disease, drug therapy, and mortality in Covid-19. N. Engl. J. Med. 382, e102 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR46","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2020","unstructured":"Guo, T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5, 811\u2013818 (2020).","journal-title":"JAMA Cardiol."},{"key":"469_CR47","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1001\/jamacardio.2020.1096","volume":"5","author":"RM Inciardi","year":"2020","unstructured":"Inciardi, R. M. et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5, 819\u2013824 (2020).","journal-title":"JAMA Cardiol."},{"key":"469_CR48","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1161\/CIRCULATIONAHA.120.047525","volume":"141","author":"GG Stefanini","year":"2020","unstructured":"Stefanini, G. G. et al. ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes. Circulation 141, 2113\u20132116 (2020).","journal-title":"Circulation"},{"key":"469_CR49","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMc2009020","volume":"382","author":"S Bangalore","year":"2020","unstructured":"Bangalore, S. et al. ST-segment elevation in patients with Covid-19 \u2013 a case series. N. Engl. J. Med. 382, 2478\u20132480 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR50","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1161\/CIRCULATIONAHA.120.047523","volume":"141","author":"M Roffi","year":"2020","unstructured":"Roffi, M., Guagliumi, G. & Ibanez, B. The obstacle course of reperfusion for STEMI in the COVID-19 pandemics. Circulation 141, 1951\u20131953 (2020).","journal-title":"Circulation"},{"key":"469_CR51","doi-asserted-by":"publisher","first-page":"31080","DOI":"10.1016\/j.jvs.2020.04.483","volume":"S0741-5214","author":"R Bellosta","year":"2020","unstructured":"Bellosta, R. et al. Acute limb ischemia in patients with COVID-19 pneumonia. J. Vasc. Surg. S0741-5214, 31080\u201331086, https:\/\/doi.org\/10.1016\/j.jvs.2020.04.483 (2020).","journal-title":"J. Vasc. Surg."},{"key":"469_CR52","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1182\/blood.2020005992","volume":"135","author":"MR DeBaun","year":"2020","unstructured":"DeBaun, M. R. Initiating adjunct low dose-hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic. Blood 135, 1997\u20131999 (2020).","journal-title":"Blood"},{"key":"469_CR53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009787","volume":"382","author":"TJ Oxley","year":"2020","unstructured":"Oxley, T. J. et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N. Engl. J. Med. 382, e60 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR54","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/ajcp\/aqaa062","volume":"153","author":"LM Barton","year":"2020","unstructured":"Barton, L. M., Duval, E. J., Stroberg, E., Ghosh, S. & Mukhopadhyay, S. COVID-19 autopsies, Oklahoma, USA. Am. J. Clin. Pathol. 153, 725\u2013733 (2020).","journal-title":"Am. J. Clin. Pathol."},{"key":"469_CR55","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.jacc.2017.02.058","volume":"69","author":"MT Corban","year":"2017","unstructured":"Corban, M. T. et al. Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics. J. Am. Coll. Cardiol. 69, 2317\u20132330 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"469_CR56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N. Engl. J. Med. 382, e38 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR57","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2020","unstructured":"Thachil, J. et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J. Thromb. Haemost. 18, 1023\u20131026 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR58","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1111\/jth.14860","volume":"18","author":"CD Barrett","year":"2020","unstructured":"Barrett, C. D., Moore, H. B., Yaffe, M. B. & Moore, E. E. ISTH interim guidance on recognition and management of coagulopathy in COVID-19: a comment. J. Thromb. Haemost. 18, 2060\u20132063 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR59","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang, N. et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 18, 1094\u20131099 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR60","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1055\/s-0040-1709650","volume":"120","author":"G Lippi","year":"2020","unstructured":"Lippi, G. & Favaloro, E. J. D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb. Haemost. 120, 876\u2013878 (2020).","journal-title":"Thromb. Haemost."},{"key":"469_CR61","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/jth.14848","volume":"18","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J. Thromb. Haemost. 18, 1469\u20131472 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR62","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","volume":"506","author":"G Lippi","year":"2020","unstructured":"Lippi, G., Plebani, M. & Henry, B. M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin. Chim. Acta 506, 145\u2013148 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"469_CR63","doi-asserted-by":"publisher","unstructured":"Yin, S., Huang, M., Li, D. & Tang, N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J. Thromb. Thrombolysis https:\/\/doi.org\/10.1007\/s11239-020-02105-8 (2020).","DOI":"10.1007\/s11239-020-02105-8"},{"key":"469_CR64","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang, N., Li, D., Wang, X. & Sun, Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 18, 844\u2013847 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR65","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor Jr","year":"2001","unstructured":"Taylor, F. B. Jr et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb. Haemost. 86, 1327\u20131330 (2001).","journal-title":"Thromb. Haemost."},{"key":"469_CR66","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/jth.14854","volume":"18","author":"M Ranucci","year":"2020","unstructured":"Ranucci, M. et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J. Thromb. Haemost. 18, 1747\u20131751 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR67","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/jth.14850","volume":"18","author":"M Panigada","year":"2020","unstructured":"Panigada, M. et al. Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost. 18, 1738\u20131742 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR68","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","volume":"58","author":"H Han","year":"2020","unstructured":"Han, H. et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin. Chem. Lab. Med. 58, 1116\u20131120 (2020).","journal-title":"Clin. Chem. Lab. Med."},{"key":"469_CR69","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","volume":"7","author":"G Goshua","year":"2020","unstructured":"Goshua, G. et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 7, e575\u2013e582 (2020).","journal-title":"Lancet Haematol."},{"key":"469_CR70","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1542\/peds.113.6.e535","volume":"113","author":"CW Leung","year":"2004","unstructured":"Leung, C. W. et al. Severe acute respiratory syndrome among children. Pediatrics 113, e535\u2013e543 (2004).","journal-title":"Pediatrics"},{"key":"469_CR71","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.120.048925","volume":"142","author":"PHG Masi","year":"2020","unstructured":"Masi, P. H. G. et al. Systemic inflammatory response syndrome is a major contributor to COVID-19-associated coagulopathy: insights from a prospective single-center cohort study. Circulation 142, 611\u2013614 (2020).","journal-title":"Circulation"},{"key":"469_CR72","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fphar.2012.00087","volume":"3","author":"WH Tang","year":"2012","unstructured":"Tang, W. H., Martin, K. A. & Hwa, J. Aldose reductase, oxidative stress, and diabetic mellitus. Front. Pharmacol. 3, 87 (2012).","journal-title":"Front. Pharmacol."},{"key":"469_CR73","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1111\/jth.15016","volume":"18","author":"C Nougier","year":"2020","unstructured":"Nougier, C. et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J. Thromb. Haemost. 18, 2215\u20132219 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR74","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1055\/s-0040-1714350","volume":"120","author":"L Spiezia","year":"2020","unstructured":"Spiezia, L. et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb. Haemost. 120, 998\u20131000 (2020).","journal-title":"Thromb. Haemost."},{"key":"469_CR75","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.29.20140376","author":"M Meizlish","year":"2020","unstructured":"Meizlish, M. et al. Circulating markers of angiogenesis and endotheliopathy in COVID-19. medRxiv https:\/\/doi.org\/10.1101\/2020.06.29.20140376 (2020).","journal-title":"medRxiv"},{"key":"469_CR76","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga, Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417\u20131418 (2020).","journal-title":"Lancet"},{"key":"469_CR77","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","volume":"8","author":"RJ Jose","year":"2020","unstructured":"Jose, R. J. & Manuel, A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir. Med. 8, e46\u2013e47 (2020).","journal-title":"Lancet Respir. Med."},{"key":"469_CR78","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 130, 2620\u20132629 (2020).","journal-title":"J. Clin. Invest."},{"key":"469_CR79","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.abb8925","volume":"368","author":"JB Moore","year":"2020","unstructured":"Moore, J. B. & June, C. H. Cytokine release syndrome in severe COVID-19. Science 368, 473\u2013474 (2020).","journal-title":"Science"},{"key":"469_CR80","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034 (2020).","journal-title":"Lancet"},{"key":"469_CR81","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad, M. & Martin, J. C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat. Rev. Immunol. 20, 355\u2013362 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"469_CR82","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463\u2013469 (2020).","journal-title":"Nature"},{"key":"469_CR83","volume":"5","author":"Y Zuo","year":"2020","unstructured":"Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight 5, e138999 (2020).","journal-title":"JCI Insight"},{"key":"469_CR84","doi-asserted-by":"publisher","first-page":"140711","DOI":"10.1172\/jci.insight.140711","volume":"5","author":"A Java","year":"2020","unstructured":"Java, A. et al. The complement system in COVID-19: friend and foe? JCI Insight 5, 140711 (2020).","journal-title":"JCI Insight"},{"key":"469_CR85","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.4049\/jimmunol.2000644","volume":"205","author":"MW Lo","year":"2020","unstructured":"Lo, M. W., Kemper, C. & Woodruff, T. M. COVID-19: complement, coagulation, and collateral damage. J. Immunol. 205, 1488\u20131495 (2020).","journal-title":"J. Immunol."},{"key":"469_CR86","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","volume":"133","author":"SP Jackson","year":"2019","unstructured":"Jackson, S. P., Darbousset, R. & Schoenwaelder, S. M. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood 133, 906\u2013918 (2019).","journal-title":"Blood"},{"key":"469_CR87","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1111\/jth.14849","volume":"18","author":"JM Connors","year":"2020","unstructured":"Connors, J. M. & Levy, J. H. Thromboinflammation and the hypercoagulability of COVID-19. J. Thromb. Haemost. 18, 1559\u20131561 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR88","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","volume":"190","author":"R Escher","year":"2020","unstructured":"Escher, R., Breakey, N. & Lammle, B. Severe COVID-19 infection associated with endothelial activation. Thromb. Res. 190, 62 (2020).","journal-title":"Thromb. Res."},{"key":"469_CR89","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","volume":"117","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc. Natl Acad. Sci. USA 117, 10970\u201310975 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR90","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/pde.14210","volume":"37","author":"C Colonna","year":"2020","unstructured":"Colonna, C. et al. Chilblain-like lesions in children following suspected Covid-19 infection. Pediatr. Dermatol. 37, 437\u2013440 (2020).","journal-title":"Pediatr. Dermatol."},{"key":"469_CR91","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","volume":"2","author":"G Cavalli","year":"2020","unstructured":"Cavalli, G. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2, e325\u2013e331 (2020).","journal-title":"Lancet Rheumatol."},{"key":"469_CR92","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10555-017-9682-0","volume":"36","author":"DG Menter","year":"2017","unstructured":"Menter, D. G. et al. Platelet \u201cfirst responders\u201d in wound response, cancer, and metastasis. Cancer Metastasis Rev. 36, 199\u2013213 (2017).","journal-title":"Cancer Metastasis Rev."},{"key":"469_CR93","doi-asserted-by":"publisher","first-page":"779","DOI":"10.15252\/emmm.201506046","volume":"8","author":"SH Lee","year":"2016","unstructured":"Lee, S. H. et al. Inducing mitophagy in diabetic platelets protects against severe oxidative stress. EMBO Mol. Med. 8, 779\u2013795 (2016).","journal-title":"EMBO Mol. Med."},{"key":"469_CR94","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1172\/JCI59291","volume":"121","author":"WH Tang","year":"2011","unstructured":"Tang, W. H. et al. Glucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane. J. Clin. Invest. 121, 4462\u20134476 (2011).","journal-title":"J. Clin. Invest."},{"key":"469_CR95","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.blre.2011.10.002","volume":"26","author":"V Leytin","year":"2012","unstructured":"Leytin, V. Apoptosis in the anucleate platelet. Blood Rev. 26, 51\u201363 (2012).","journal-title":"Blood Rev."},{"key":"469_CR96","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1126\/science.328.5978.562","volume":"328","author":"M Leslie","year":"2010","unstructured":"Leslie, M. Cell biology. Beyond clotting: the powers of platelets. Science 328, 562\u2013564 (2010).","journal-title":"Science"},{"key":"469_CR97","doi-asserted-by":"publisher","first-page":"642","DOI":"10.4161\/auto.27832","volume":"10","author":"W Feng","year":"2014","unstructured":"Feng, W. et al. Dissection of autophagy in human platelets. Autophagy 10, 642\u2013651 (2014).","journal-title":"Autophagy"},{"key":"469_CR98","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1182\/blood-2014-09-598722","volume":"126","author":"MM Ouseph","year":"2015","unstructured":"Ouseph, M. M. et al. Autophagy is induced upon platelet activation and is essential for hemostasis and thrombosis. Blood 126, 1224\u20131233 (2015).","journal-title":"Blood"},{"key":"469_CR99","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","volume":"128","author":"KD Mason","year":"2007","unstructured":"Mason, K. D. et al. Programmed anuclear cell death delimits platelet life span. Cell 128, 1173\u20131186 (2007).","journal-title":"Cell"},{"key":"469_CR100","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1083\/jcb.200105058","volume":"154","author":"S Lindemann","year":"2001","unstructured":"Lindemann, S. et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1\u03b2 synthesis. J. Cell Biol. 154, 485\u2013490 (2001).","journal-title":"J. Cell Biol."},{"key":"469_CR101","doi-asserted-by":"publisher","first-page":"5556","DOI":"10.1073\/pnas.95.10.5556","volume":"95","author":"AS Weyrich","year":"1998","unstructured":"Weyrich, A. S. et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc. Natl Acad. Sci. USA 95, 5556\u20135561 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"469_CR102","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.immuni.2016.01.008","volume":"44","author":"WJ Chae","year":"2016","unstructured":"Chae, W. J. et al. The Wnt antagonist Dickkopf-1 promotes pathological type 2 cell-mediated inflammation. Immunity 44, 246\u2013258 (2016).","journal-title":"Immunity"},{"key":"469_CR103","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","volume":"122","author":"M Koupenova","year":"2018","unstructured":"Koupenova, M., Clancy, L., Corkrey, H. A. & Freedman, J. E. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ. Res. 122, 337\u2013351 (2018).","journal-title":"Circ. Res."},{"key":"469_CR104","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1161\/ATVBAHA.120.314620","volume":"40","author":"M Koupenova","year":"2020","unstructured":"Koupenova, M. & Freedman, J. E. Platelets and immunity: going viral. Arterioscler. Thromb. Vasc. Biol. 40, 1605\u20131607 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"469_CR105","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa030634","volume":"348","author":"SM Poutanen","year":"2003","unstructured":"Poutanen, S. M. et al. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348, 1995\u20132005 (2003).","journal-title":"N. Engl. J. Med."},{"key":"469_CR106","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1056\/NEJMoa030666","volume":"348","author":"KW Tsang","year":"2003","unstructured":"Tsang, K. W. et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348, 1977\u20131985 (2003).","journal-title":"N. Engl. J. Med."},{"key":"469_CR107","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJMoa030685","volume":"348","author":"N Lee","year":"2003","unstructured":"Lee, N. et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348, 1986\u20131994 (2003).","journal-title":"N. Engl. J. Med."},{"key":"469_CR108","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","volume":"361","author":"JSM Peiris","year":"2003","unstructured":"Peiris, J. S. M. et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 1767\u20131772 (2003).","journal-title":"Lancet"},{"key":"469_CR109","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1378\/chest.126.2.509","volume":"126","author":"C-L Liu","year":"2004","unstructured":"Liu, C.-L. et al. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever. Chest 126, 509\u2013517 (2004).","journal-title":"Chest"},{"key":"469_CR110","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3201\/eid1005.030640","volume":"10","author":"J-T Wang","year":"2004","unstructured":"Wang, J.-T. et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg. Infect. Dis. 10, 818\u2013824 (2004).","journal-title":"Emerg. Infect. Dis."},{"key":"469_CR111","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1080\/00313020310001619118","volume":"35","author":"Z-W Lang","year":"2003","unstructured":"Lang, Z.-W. et al. A clinicopathological study of three cases of severe acute respiratory syndrome (SARS). Pathology 35, 526\u2013531 (2003).","journal-title":"Pathology"},{"key":"469_CR112","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/S0140-6736(03)13364-8","volume":"361","author":"KLE Hon","year":"2003","unstructured":"Hon, K. L. E. et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 361, 1701\u20131703 (2003).","journal-title":"Lancet"},{"key":"469_CR113","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/bmj.326.7403.1358","volume":"326","author":"RSM Wong","year":"2003","unstructured":"Wong, R. S. M. et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 326, 1358\u20131362 (2003).","journal-title":"BMJ"},{"key":"469_CR114","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7326\/0003-4819-139-9-200311040-00005","volume":"139","author":"KW Choi","year":"2003","unstructured":"Choi, K. W. et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann. Intern. Med. 139, 715\u2013723 (2003).","journal-title":"Ann. Intern. Med."},{"key":"469_CR115","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa1303729","volume":"368","author":"ZA Memish","year":"2013","unstructured":"Memish, Z. A., Zumla, A. I., Al-Hakeem, R. F., Al-Rabeeah, A. A. & Stephens, G. M. Family cluster of Middle East respiratory syndrome coronavirus infections. N. Engl. J. Med. 368, 2487\u20132494 (2013).","journal-title":"N. Engl. J. Med."},{"key":"469_CR116","doi-asserted-by":"publisher","first-page":"e668","DOI":"10.1016\/j.ijid.2013.07.001","volume":"17","author":"AS Omrani","year":"2013","unstructured":"Omrani, A. S. et al. A family cluster of Middle East respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int. J. Infect. Dis. 17, e668\u2013e672 (2013).","journal-title":"Int. J. Infect. Dis."},{"key":"469_CR117","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1306742","volume":"369","author":"A Assiri","year":"2013","unstructured":"Assiri, A. et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N. Engl. J. Med. 369, 407\u2013416 (2013).","journal-title":"N. Engl. J. Med."},{"key":"469_CR118","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","volume":"13","author":"A Assiri","year":"2013","unstructured":"Assiri, A. et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 13, 752\u2013761 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"469_CR119","doi-asserted-by":"publisher","first-page":"389","DOI":"10.7326\/M13-2486","volume":"160","author":"YM Arabi","year":"2014","unstructured":"Arabi, Y. M. et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann. Int. Med. 160, 389\u2013397 (2014).","journal-title":"Ann. Int. Med."},{"key":"469_CR120","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ijlh.12620","volume":"39","author":"JA Al-Tawfiq","year":"2017","unstructured":"Al-Tawfiq, J. A. et al. Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus. Int. J. Lab. Hematol. 39, 272\u2013278 (2017).","journal-title":"Int. J. Lab. Hematol."},{"key":"469_CR121","doi-asserted-by":"publisher","first-page":"m606","DOI":"10.1136\/bmj.m606","volume":"368","author":"X-W Xu","year":"2020","unstructured":"Xu, X.-W. et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 368, m606 (2020).","journal-title":"BMJ"},{"key":"469_CR122","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jinf.2020.02.016","volume":"80","author":"W Yang","year":"2020","unstructured":"Yang, W. et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou City, Zhejiang, China. J. Infect. 80, 388\u2013393 (2020).","journal-title":"J. Infect."},{"key":"469_CR123","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12931-020-01338-8","volume":"21","author":"G Zhang","year":"2020","unstructured":"Zhang, G. et al. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir. Res. 21, 74 (2020).","journal-title":"Respir. Res."},{"key":"469_CR124","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"JF-W Chan","year":"2020","unstructured":"Chan, J. F.-W. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395, 514\u2013523 (2020).","journal-title":"Lancet"},{"key":"469_CR125","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1111\/bjh.16950","volume":"190","author":"J Maquet","year":"2020","unstructured":"Maquet, J. et al. Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19. Br. J. Haematol. 190, e276\u2013e279 (2020).","journal-title":"Br. J. Haematol."},{"key":"469_CR126","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1182\/blood.2020006520","volume":"136","author":"H Al-Samkari","year":"2020","unstructured":"Al-Samkari, H. et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 136, 489\u2013500 (2020).","journal-title":"Blood"},{"key":"469_CR127","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1182\/blood.2020007214","volume":"136","author":"BK Manne","year":"2020","unstructured":"Manne, B. K. et al. Platelet gene expression and function in COVID-19 patients. Blood 136, 1317\u20131329 (2020).","journal-title":"Blood"},{"key":"469_CR128","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.113.005224","volume":"129","author":"WH Tang","year":"2014","unstructured":"Tang, W. H. et al. Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction, and damage in diabetic platelets. Circulation 129, 1598\u20131609 (2014).","journal-title":"Circulation"},{"key":"469_CR129","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1160\/TH06-06-0313","volume":"97","author":"EI Sinauridze","year":"2007","unstructured":"Sinauridze, E. I. et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb. Haemost. 97, 425\u2013434 (2007).","journal-title":"Thromb. Haemost."},{"key":"469_CR130","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","volume":"8","author":"SE Fox","year":"2020","unstructured":"Fox, S. E. et al. Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans. Lancet Respir. Med. 8, 681\u2013686 (2020).","journal-title":"Lancet Respir. Med."},{"key":"469_CR131","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fendo.2013.00077","volume":"4","author":"JL Fitch-Tewfik","year":"2013","unstructured":"Fitch-Tewfik, J. L. & Flaumenhaft, R. Platelet granule exocytosis: a comparison with chromaffin cells. Front. Endocrinol. 4, 77 (2013).","journal-title":"Front. Endocrinol."},{"key":"469_CR132","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fmed.2018.00042","volume":"5","author":"C Sut","year":"2018","unstructured":"Sut, C. et al. The non-hemostatic aspects of transfused platelets. Front. Med. 5, 42 (2018).","journal-title":"Front. Med."},{"key":"469_CR133","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye, Q., Wang, B. & Mao, J. The pathogenesis and treatment of the \u2018cytokine storm\u2019 in COVID-19. J. Infect. 80, 607\u2013613 (2020).","journal-title":"J. Infect."},{"key":"469_CR134","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1182\/blood-2013-05-504449","volume":"122","author":"ED Hottz","year":"2013","unstructured":"Hottz, E. D. et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood 122, 3405\u20133414 (2013).","journal-title":"Blood"},{"key":"469_CR135","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1182\/blood.2020007008","volume":"136","author":"EA Middleton","year":"2020","unstructured":"Middleton, E. A. et al. Neutrophil extracellular Traps (NETs) contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136, 1169\u20131179 (2020).","journal-title":"Blood"},{"key":"469_CR136","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.blre.2006.06.001","volume":"21","author":"A Zarbock","year":"2007","unstructured":"Zarbock, A., Polanowska-Grabowska, R. K. & Ley, K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev. 21, 99\u2013111 (2007).","journal-title":"Blood Rev."},{"key":"469_CR137","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S2352-3026(20)30109-5","volume":"7","author":"T Wang","year":"2020","unstructured":"Wang, T. et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 7, e362\u2013e363 (2020).","journal-title":"Lancet Haematol."},{"key":"469_CR138","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fcvm.2019.00153","volume":"6","author":"H Melchinger","year":"2019","unstructured":"Melchinger, H., Jain, K., Tyagi, T. & Hwa, J. Role of platelet mitochondria: life in a nucleus-free zone. Front. Cardiovasc. Med. 6, 153 (2019).","journal-title":"Front. Cardiovasc. Med."},{"key":"469_CR139","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1182\/blood-2015-01-569129","volume":"126","author":"R Grozovsky","year":"2015","unstructured":"Grozovsky, R., Giannini, S., Falet, H. & Hoffmeister, K. M. Regulating billions of blood platelets: glycans and beyond. Blood 126, 1877\u20131884 (2015).","journal-title":"Blood"},{"key":"469_CR140","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2010472","volume":"382","author":"AA Zulfiqar","year":"2020","unstructured":"Zulfiqar, A. A., Lorenzo-Villalba, N., Hassler, P. & Andres, E. Immune thrombocytopenic purpura in a patient with Covid-19. N. Engl. J. Med. 382, e43 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR141","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1182\/blood-2013-05-501924","volume":"123","author":"T Tyagi","year":"2014","unstructured":"Tyagi, T. et al. Altered expression of platelet proteins and calpain activity mediate hypoxia-induced prothrombotic phenotype. Blood 123, 1250\u20131260 (2014).","journal-title":"Blood"},{"key":"469_CR142","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/thx.2010.157529","volume":"66","author":"JD Maclay","year":"2011","unstructured":"Maclay, J. D. et al. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax 66, 769\u2013774 (2011).","journal-title":"Thorax"},{"key":"469_CR143","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000621","volume":"7","author":"GP Burns","year":"2020","unstructured":"Burns, G. P. et al. Improved survival following ward-based non-invasive pressure support for severe hypoxia in a cohort of frail patients with COVID-19: retrospective analysis from a UK teaching hospital. BMJ Open Respir. Res. 7, e000621 (2020).","journal-title":"BMJ Open Respir. Res."},{"key":"469_CR144","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.120.047419","volume":"141","author":"CM Campbell","year":"2020","unstructured":"Campbell, C. M. & Kahwash, R. Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? Circulation 141, 1739\u20131741 (2020).","journal-title":"Circulation"},{"key":"469_CR145","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41569-020-0368-x","volume":"17","author":"JJ Mourad","year":"2020","unstructured":"Mourad, J. J. & Levy, B. I. Interaction between RAAS inhibitors and ACE2 in the context of COVID-19. Nat. Rev. Cardiol. 17, 313 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"469_CR146","doi-asserted-by":"publisher","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","volume":"318","author":"AM South","year":"2020","unstructured":"South, A. M., Diz, D. I. & Chappell, M. C. COVID-19, ACE2, and the cardiovascular consequences. Am. J. Physiol. Heart Circ. Physiol. 318, H1084\u2013H1090 (2020).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"469_CR147","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1182\/blood-2001-12-0191","volume":"99","author":"T Youssefian","year":"2002","unstructured":"Youssefian, T., Drouin, A., Masse, J. M., Guichard, J. & Cramer, E. M. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 99, 4021\u20134029 (2002).","journal-title":"Blood"},{"key":"469_CR148","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1182\/blood-2011-08-376822","volume":"121","author":"GD Loria","year":"2013","unstructured":"Loria, G. D., Romagnoli, P. A., Moseley, N. B., Rucavado, A. & Altman, J. D. Platelets support a protective immune response to LCMV by preventing splenic necrosis. Blood 121, 940\u2013950 (2013).","journal-title":"Blood"},{"key":"469_CR149","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1378\/chest.11-2860","volume":"141","author":"MT Rondina","year":"2012","unstructured":"Rondina, M. T. et al. In vivo platelet activation in critically ill patients with primary 2009 influenza A (H1N1). Chest 141, 1490\u20131495 (2012).","journal-title":"Chest"},{"key":"469_CR150","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3390\/ijms20071730","volume":"20","author":"C Gomez-Casado","year":"2019","unstructured":"Gomez-Casado, C. et al. Understanding platelets in infectious and allergic lung diseases. Int. J. Mol. Sci. 20, 1730 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"469_CR151","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1152\/physrev.00038.2015","volume":"96","author":"EA Middleton","year":"2016","unstructured":"Middleton, E. A., Weyrich, A. S. & Zimmerman, G. A. Platelets in pulmonary immune responses and inflammatory lung diseases. Physiol. Rev. 96, 1211\u20131259 (2016).","journal-title":"Physiol. Rev."},{"key":"469_CR152","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1016\/j.celrep.2018.11.081","volume":"25","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z. et al. Structural analyses of Toll-like receptor 7 reveal detailed RNA sequence specificity and recognition mechanism of agonistic ligands. Cell Rep. 25, 3371\u20133381.e5 (2018).","journal-title":"Cell Rep."},{"key":"469_CR153","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1161\/ATVBAHA.114.304954","volume":"35","author":"M Koupenova","year":"2015","unstructured":"Koupenova, M. et al. Sex differences in platelet toll-like receptors and their association with cardiovascular risk factors. Arterioscler. Thromb. Vasc. Biol. 35, 1030\u20131037 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"469_CR154","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1182\/blood-2013-11-536003","volume":"124","author":"M Koupenova","year":"2014","unstructured":"Koupenova, M. et al. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood 124, 791\u2013802 (2014).","journal-title":"Blood"},{"key":"469_CR155","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/10245330400026170","volume":"10","author":"M Yang","year":"2005","unstructured":"Yang, M., Ng, M. H. & Li, C. K. Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology 10, 101\u2013105 (2005).","journal-title":"Hematology"},{"key":"469_CR156","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1182\/blood-2016-11-749879","volume":"129","author":"S Subramaniam","year":"2017","unstructured":"Subramaniam, S. et al. Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood 129, 2291\u20132302 (2017).","journal-title":"Blood"},{"key":"469_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","volume":"220","author":"C Magro","year":"2020","unstructured":"Magro, C. et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl. Res. 220, 1\u201313 (2020).","journal-title":"Transl. Res."},{"key":"469_CR158","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1182\/blood-2003-08-2804","volume":"103","author":"JA Coppinger","year":"2004","unstructured":"Coppinger, J. A. et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103, 2096\u20132104 (2004).","journal-title":"Blood"},{"key":"469_CR159","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09160-7","volume":"10","author":"J Perdomo","year":"2019","unstructured":"Perdomo, J. et al. Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia. Nat. Commun. 10, 1322 (2019).","journal-title":"Nat. Commun."},{"key":"469_CR160","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nm.2262","volume":"17","author":"AC Monsalvo","year":"2011","unstructured":"Monsalvo, A. C. et al. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat. Med. 17, 195\u2013199 (2011).","journal-title":"Nat. Med."},{"key":"469_CR161","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1182\/blood-2013-07-515536","volume":"123","author":"E Boilard","year":"2014","unstructured":"Boilard, E. et al. Influenza virus H1N1 activates platelets through Fc\u03b3RIIA signaling and thrombin generation. Blood 123, 2854\u20132863 (2014).","journal-title":"Blood"},{"key":"469_CR162","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00018-009-0209-x","volume":"67","author":"C Flaujac","year":"2010","unstructured":"Flaujac, C., Boukour, S. & Cramer-Borde, E. Platelets and viruses: an ambivalent relationship. Cell Mol. Life Sci. 67, 545\u2013556 (2010).","journal-title":"Cell Mol. Life Sci."},{"key":"469_CR163","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature21706","volume":"544","author":"E Lefran\u00e7ais","year":"2017","unstructured":"Lefran\u00e7ais, E. et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature 544, 105\u2013109 (2017).","journal-title":"Nature"},{"key":"469_CR164","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1152\/physiol.00017.2019","volume":"34","author":"E Lefrancais","year":"2019","unstructured":"Lefrancais, E. & Looney, M. R. Platelet biogenesis in the lung circulation. Physiology 34, 392\u2013401 (2019).","journal-title":"Physiology"},{"key":"469_CR165","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fmed.2018.00121","volume":"5","author":"ED Hottz","year":"2018","unstructured":"Hottz, E. D., Bozza, F. A. & Bozza, P. T. Platelets in immune response to virus and immunopathology of viral infections. Front. Med. 5, 121 (2018).","journal-title":"Front. Med."},{"key":"469_CR166","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1182\/bloodadvances.2018019448","volume":"2","author":"NT Rahman","year":"2018","unstructured":"Rahman, N. T. et al. MRTFA augments megakaryocyte maturation by enhancing the SRF regulatory axis. Blood Adv. 2, 2691\u20132703 (2018).","journal-title":"Blood Adv."},{"key":"469_CR167","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.44031","volume":"8","author":"P Cunin","year":"2019","unstructured":"Cunin, P. et al. Megakaryocyte emperipolesis mediates membrane transfer from intracytoplasmic neutrophils to platelets. eLife 8, e44031 (2019).","journal-title":"eLife"},{"key":"469_CR168","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","volume":"20","author":"LA Teuwen","year":"2020","unstructured":"Teuwen, L. A., Geldhof, V., Pasut, A. & Carmeliet, P. COVID-19: the vasculature unleashed. Nat. Rev. Immunol. 20, 389\u2013391 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"469_CR169","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1016\/S2352-3026(20)30215-5","volume":"7","author":"JM O\u2019Sullivan","year":"2020","unstructured":"O\u2019Sullivan, J. M., Gonagle, D. M., Ward, S. E., Preston, R. J. S. & O\u2019Donnell, J. S. Endothelial cells orchestrate COVID-19 coagulopathy. Lancet Haematol. 7, e553\u2013e555 (2020).","journal-title":"Lancet Haematol."},{"key":"469_CR170","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler, C. G. K. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016\u20131035.e19 (2020).","journal-title":"Cell"},{"key":"469_CR171","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1164\/rccm.202001-0179LE","volume":"202","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. Am. J. Respir. Crit. Care Med. 202, 756\u2013759 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"469_CR172","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nri2171","volume":"7","author":"JS Pober","year":"2007","unstructured":"Pober, J. S. & Sessa, W. C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7, 803\u2013815 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"469_CR173","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","volume":"20","author":"AM Risitano","year":"2020","unstructured":"Risitano, A. M. et al. Complement as a target in COVID-19? Nat. Rev. Immunol. 20, 343\u2013344 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"469_CR174","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMra1705454","volume":"378","author":"D Garcia","year":"2018","unstructured":"Garcia, D. & Erkan, D. Diagnosis and management of the antiphospholipid syndrome. N. Engl. J. Med. 378, 2010\u20132021 (2018).","journal-title":"N. Engl. J. Med."},{"key":"469_CR175","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJMc2013656","volume":"383","author":"L Bowles","year":"2020","unstructured":"Bowles, L. et al. Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19. N. Engl. J. Med. 383, 288\u2013290 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR176","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1111\/jth.14867","volume":"18","author":"I Harzallah","year":"2020","unstructured":"Harzallah, I., Debliquis, A. & Drenou, B. Lupus anticoagulant is frequent in patients with Covid-19. J. Thromb. Haemost. 18, 2064\u20132065 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR177","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1182\/blood-2014-02-554980","volume":"124","author":"V Proulle","year":"2014","unstructured":"Proulle, V., Furie, R. A., Merrill-Skoloff, G., Furie, B. C. & Furie, B. Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS. Blood 124, 611\u2013622 (2014).","journal-title":"Blood"},{"key":"469_CR178","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMra1112830","volume":"368","author":"B Giannakopoulos","year":"2013","unstructured":"Giannakopoulos, B. & Krilis, S. A. The pathogenesis of the antiphospholipid syndrome. N. Engl. J. Med. 368, 1033\u20131044 (2013).","journal-title":"N. Engl. J. Med."},{"key":"469_CR179","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/nrrheum.2012.118","volume":"8","author":"E Boilard","year":"2012","unstructured":"Boilard, E., Blanco, P. & Nigrovic, P. A. Platelets: active players in the pathogenesis of arthritis and SLE. Nat. Rev. Rheumatol. 8, 534\u2013542 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"469_CR180","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1182\/blood-2017-11-814681","volume":"131","author":"A Sacharidou","year":"2018","unstructured":"Sacharidou, A. et al. Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium. Blood 131, 2097\u20132110 (2018).","journal-title":"Blood"},{"key":"469_CR181","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1182\/blood.2019003863","volume":"135","author":"S Chaturvedi","year":"2019","unstructured":"Chaturvedi, S. et al. Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS. Blood 135, 239\u2013251 (2019).","journal-title":"Blood"},{"key":"469_CR182","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/sarh.2002.28303","volume":"31","author":"IW Uthman","year":"2002","unstructured":"Uthman, I. W. & Gharavi, A. E. Viral infections and antiphospholipid antibodies. Semin. Arthritis Rheum. 31, 256\u2013263 (2002).","journal-title":"Semin. Arthritis Rheum."},{"key":"469_CR183","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-0032-1304714","volume":"38","author":"G Lakos","year":"2012","unstructured":"Lakos, G. Interference in antiphospholipid antibody assays. Semin. Thromb. Hemost. 38, 353\u2013359 (2012).","journal-title":"Semin. Thromb. Hemost."},{"key":"469_CR184","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","volume":"7","author":"V Pengo","year":"2009","unstructured":"Pengo, V. et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J. Thromb. Haemost. 7, 1737\u20131740 (2009).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR185","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jaad.2020.04.161","volume":"83","author":"A de Masson","year":"2020","unstructured":"de Masson, A. et al. Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France. J. Am. Acad. Dermatol. 83, 667\u2013670 (2020).","journal-title":"J. Am. Acad. Dermatol."},{"key":"469_CR186","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J. & Prescott, H. C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324, 782\u2013793 (2020).","journal-title":"JAMA"},{"key":"469_CR187","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/01.RES.0000020401.61826.EA","volume":"90","author":"A Csiszar","year":"2002","unstructured":"Csiszar, A. et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ. Res. 90, 1159\u20131166 (2002).","journal-title":"Circ. Res."},{"key":"469_CR188","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1113\/jphysiol.2011.211219","volume":"589","author":"AJ Donato","year":"2011","unstructured":"Donato, A. J. et al. SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J. Physiol. 589, 4545\u20134554 (2011).","journal-title":"J. Physiol."},{"key":"469_CR189","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/01.CIR.0000048893.62841.F7","volume":"107","author":"EG Lakatta","year":"2003","unstructured":"Lakatta, E. G. & Levy, D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 107, 346\u2013354 (2003).","journal-title":"Circulation"},{"key":"469_CR190","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0735-1097(03)00994-X","volume":"42","author":"ME Widlansky","year":"2003","unstructured":"Widlansky, M. E., Gokce, N., Keaney, J. F. Jr & Vita, J. A. The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol. 42, 1149\u20131160 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"469_CR191","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41569-018-0030-z","volume":"15","author":"Z Ungvari","year":"2018","unstructured":"Ungvari, Z. et al. Endothelial dysfunction and angiogenesis impairment in the ageing vasculature. Nat. Rev. Cardiol. 15, 555\u2013565 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"469_CR192","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1161\/01.RES.0000269183.13937.e8","volume":"100","author":"AJ Donato","year":"2007","unstructured":"Donato, A. J. et al. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-\u03baB. Circ. Res. 100, 1659\u20131666 (2007).","journal-title":"Circ. Res."},{"key":"469_CR193","doi-asserted-by":"publisher","first-page":"H1015","DOI":"10.1152\/ajpheart.01047.2002","volume":"285","author":"A Adler","year":"2003","unstructured":"Adler, A. et al. NAD(P)H oxidase-generated superoxide anion accounts for reduced control of myocardial O2 consumption by NO in old Fischer 344 rats. Am. J. Physiol. Heart Circ. Physiol. 285, H1015\u2013H1022 (2003).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"469_CR194","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.CIR.0000153339.27064.14","volume":"111","author":"A Lerman","year":"2005","unstructured":"Lerman, A. & Zeiher, A. M. Endothelial function: cardiac events. Circulation 111, 363\u2013368 (2005).","journal-title":"Circulation"},{"key":"469_CR195","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCRESAHA.111.246140","volume":"110","author":"DF Dai","year":"2012","unstructured":"Dai, D. F., Rabinovitch, P. S. & Ungvari, Z. Mitochondria and cardiovascular aging. Circ. Res. 110, 1109\u20131124 (2012).","journal-title":"Circ. Res."},{"key":"469_CR196","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physiolgenomics.00136.2003","volume":"17","author":"A Csiszar","year":"2004","unstructured":"Csiszar, A., Ungvari, Z., Koller, A., Edwards, J. G. & Kaley, G. Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. Physiol. Genomics 17, 21\u201330 (2004).","journal-title":"Physiol. Genomics"},{"key":"469_CR197","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1161\/01.ATV.20.6.1493","volume":"20","author":"K Asai","year":"2000","unstructured":"Asai, K. et al. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler. Thromb. Vasc. Biol. 20, 1493\u20131499 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"469_CR198","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11357-019-00074-2","volume":"41","author":"T Kiss","year":"2019","unstructured":"Kiss, T. et al. Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment. Geroscience 41, 619\u2013630 (2019).","journal-title":"Geroscience"},{"key":"469_CR199","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11357-019-00101-2","volume":"41","author":"S Tarantini","year":"2019","unstructured":"Tarantini, S. et al. Treatment with the poly(ADP-ribose) polymerase inhibitor PJ-34 improves cerebromicrovascular endothelial function, neurovascular coupling responses and cognitive performance in aged mice, supporting the NAD+ depletion hypothesis of neurovascular aging. Geroscience 41, 533\u2013542 (2019).","journal-title":"Geroscience"},{"key":"469_CR200","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s11357-019-00107-w","volume":"41","author":"Z Ungvari","year":"2019","unstructured":"Ungvari, Z. et al. Nrf2 dysfunction and impaired cellular resilience to oxidative stressors in the aged vasculature: from increased cellular senescence to the pathogenesis of age-related vascular diseases. Geroscience 41, 727\u2013738 (2019).","journal-title":"Geroscience"},{"key":"469_CR201","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/antiox9060518","volume":"9","author":"JM McCord","year":"2020","unstructured":"McCord, J. M., Hybertson, B. M., Cota-Gomez, A., Geraci, K. P. & Gao, B. Nrf2 activator PB125((R)) as a potential therapeutic agent against COVID-19. Antioxidants 9, 518 (2020).","journal-title":"Antioxidants"},{"key":"469_CR202","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","volume":"395","author":"S Riphagen","year":"2020","unstructured":"Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N. & Theocharis, P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 395, 1607\u20131608 (2020).","journal-title":"Lancet"},{"key":"469_CR203","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","volume":"395","author":"L Verdoni","year":"2020","unstructured":"Verdoni, L. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 395, 1771\u20131778 (2020).","journal-title":"Lancet"},{"key":"469_CR204","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(20)31129-6","volume":"395","author":"RM Viner","year":"2020","unstructured":"Viner, R. M. & Whittaker, E. Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet 395, 1741\u20131743 (2020).","journal-title":"Lancet"},{"key":"469_CR205","volume":"8","author":"EW Cheung","year":"2020","unstructured":"Cheung, E. W. et al. Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA 8, e2010374 (2020).","journal-title":"JAMA"},{"key":"469_CR206","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein, L. R. et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 383, 334\u2013346 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR207","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort, E. M. et al. Multisystem inflammatory syndrome in children in New York State. N. Engl. J. Med. 383, 347\u2013358 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR208","unstructured":"CDC. Emergency preparedness and response. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). CDC https:\/\/emergency.cdc.gov\/han\/2020\/han00432.asp (2020)."},{"key":"469_CR209","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao, X. COVID-19: immunopathology and its implications for therapy. Nat. Rev. Immunol. 20, 269\u2013270 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"469_CR210","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038998","volume":"7","author":"JM Orenstein","year":"2012","unstructured":"Orenstein, J. M. et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS ONE 7, e38998 (2012).","journal-title":"PLoS ONE"},{"key":"469_CR211","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/CIRCRESAHA.120.316951","volume":"127","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Reduced platelet miR-223 induction in Kawasaki disease leads to severe coronary artery pathology through a miR-223\/PDGFR\u03b2 vascular smooth muscle cell axis. Circ. Res. 127, 855\u2013873 (2020).","journal-title":"Circ. Res."},{"key":"469_CR212","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1161\/01.CIR.94.9.2103","volume":"94","author":"R Dhillon","year":"1996","unstructured":"Dhillon, R. et al. Endothelial dysfunction late after Kawasaki disease. Circulation 94, 2103\u20132106 (1996).","journal-title":"Circulation"},{"key":"469_CR213","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1056\/NEJM198701013160102","volume":"316","author":"DJ Murphy Jr.","year":"1987","unstructured":"Murphy, D. J. Jr. & Huhta, J. C. Treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 316, 881 (1987).","journal-title":"N. Engl. J. Med."},{"key":"469_CR214","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","volume":"324","author":"JW Newburger","year":"1991","unstructured":"Newburger, J. W. et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N. Engl. J. Med. 324, 1633\u20131639 (1991).","journal-title":"N. Engl. J. Med."},{"key":"469_CR215","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJM198608073150601","volume":"315","author":"JW Newburger","year":"1986","unstructured":"Newburger, J. W. et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 315, 341\u2013347 (1986).","journal-title":"N. Engl. J. Med."},{"key":"469_CR216","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","volume":"2","author":"K Furusho","year":"1984","unstructured":"Furusho, K. et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2, 1055\u20131058 (1984).","journal-title":"Lancet"},{"key":"469_CR217","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(83)91109-1","volume":"2","author":"K Furusho","year":"1983","unstructured":"Furusho, K. et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2, 1359 (1983).","journal-title":"Lancet"},{"key":"469_CR218","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/288373a0","volume":"288","author":"RF Furchgott","year":"1980","unstructured":"Furchgott, R. F. & Zawadzki, J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288, 373\u2013376 (1980).","journal-title":"Nature"},{"key":"469_CR219","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/0090-6980(76)90125-8","volume":"12","author":"S Bunting","year":"1976","unstructured":"Bunting, S., Gryglewski, R., Moncada, S. & Vane, J. R. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins 12, 897\u2013913 (1976).","journal-title":"Prostaglandins"},{"key":"469_CR220","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1476-5381.1983.tb10020.x","volume":"79","author":"JR Vane","year":"1983","unstructured":"Vane, J. R. Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin. Br. J. Pharmacol. 79, 821\u2013838 (1983).","journal-title":"Br. J. Pharmacol."},{"key":"469_CR221","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1056\/NEJM199303043280907","volume":"328","author":"JA Ware","year":"1993","unstructured":"Ware, J. A. & Heistad, D. D. Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions. N. Engl. J. Med. 328, 628\u2013635 (1993).","journal-title":"N. Engl. J. Med."},{"key":"469_CR222","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1182\/blood.V79.1.91.91","volume":"79","author":"WF Penny","year":"1992","unstructured":"Penny, W. F. & Ware, J. A. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator. Blood 79, 91\u201398 (1992).","journal-title":"Blood"},{"key":"469_CR223","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1172\/JCI113015","volume":"79","author":"J Loscalzo","year":"1987","unstructured":"Loscalzo, J. & Vaughan, D. E. Tissue plasminogen activator promotes platelet disaggregation in plasma. J. Clin. Invest. 79, 1749\u20131755 (1987).","journal-title":"J. Clin. Invest."},{"key":"469_CR224","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00277-020-04097-0","volume":"99","author":"N Albiol","year":"2020","unstructured":"Albiol, N., Awol, R. & Martino, R. Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19. Ann. Hematol. 99, 1673\u20131674 (2020).","journal-title":"Ann. Hematol."},{"key":"469_CR225","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.thromres.2020.07.005","volume":"195","author":"F Hindilerden","year":"2020","unstructured":"Hindilerden, F., Yonal-Hindilerden, I., Akar, E. & Kart-Yasar, K. Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: report of a case. Thromb. Res. 195, 136\u2013138 (2020).","journal-title":"Thromb. Res."},{"key":"469_CR226","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1182\/blood-2017-04-780825","volume":"130","author":"DM Coenen","year":"2017","unstructured":"Coenen, D. M., Mastenbroek, T. G. & Cosemans, J. Platelet interaction with activated endothelium: mechanistic insights from microfluidics. Blood 130, 2819\u20132828 (2017).","journal-title":"Blood"},{"key":"469_CR227","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.2337\/dc08-s246","volume":"31","author":"E Grossman","year":"2008","unstructured":"Grossman, E. Does increased oxidative stress cause hypertension? Diabetes Care 31, S185\u2013S189 (2008).","journal-title":"Diabetes Care"},{"key":"469_CR228","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/hr.2010.264","volume":"34","author":"R Rodrigo","year":"2011","unstructured":"Rodrigo, R., Gonzalez, J. & Paoletto, F. The role of oxidative stress in the pathophysiology of hypertension. Hypertens. Res. 34, 431\u2013440 (2011).","journal-title":"Hypertens. Res."},{"key":"469_CR229","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ebiom.2019.05.022","volume":"44","author":"K Jain","year":"2019","unstructured":"Jain, K. et al. Age associated non-linear regulation of redox homeostasis in the anucleate platelet: implications for CVD risk patients. EBioMedicine 44, 28\u201340 (2019).","journal-title":"EBioMedicine"},{"key":"469_CR230","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ebiom.2019.08.047","volume":"47","author":"K Jain","year":"2019","unstructured":"Jain, K., Tyagi, T., Ionescu, C. N. & Hwa, J. Author\u2019s response to \u201cplatelet antioxidants: A conundrum in aging\u201d. EBioMedicine 47, 31\u201332 (2019).","journal-title":"EBioMedicine"},{"key":"469_CR231","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.chest.2017.11.031","volume":"154","author":"CP Aaron","year":"2018","unstructured":"Aaron, C. P. et al. A longitudinal cohort study of aspirin use and progression of emphysema-like lung characteristics on CT imaging: the MESA lung study. Chest 154, 41\u201350 (2018).","journal-title":"Chest"},{"key":"469_CR232","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1097\/01.ASN.0000032417.73640.72","volume":"13","author":"S Mitchell","year":"2002","unstructured":"Mitchell, S. et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J. Am. Soc. Nephrol. 13, 2497\u20132507 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"469_CR233","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1182\/blood-2015-01-620278","volume":"125","author":"Y Xiang","year":"2015","unstructured":"Xiang, Y. et al. Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor. Blood 125, 3377\u20133387 (2015).","journal-title":"Blood"},{"key":"469_CR234","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/MOH.0000000000000230","volume":"23","author":"Y Xiang","year":"2016","unstructured":"Xiang, Y. & Hwa, J. Regulation of VWF expression, and secretion in health and disease. Curr. Opin. Hematol. 23, 288\u2013293 (2016).","journal-title":"Curr. Opin. Hematol."},{"key":"469_CR235","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ncpendmet0366","volume":"3","author":"C Rask-Madsen","year":"2007","unstructured":"Rask-Madsen, C. & King, G. L. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat. Clin. Pract. Endocrinol. Metab. 3, 46\u201356 (2007).","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"469_CR236","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1001\/jama.291.16.1978","volume":"291","author":"JB Meigs","year":"2004","unstructured":"Meigs, J. B., Hu, F. B., Rifai, N. & Manson, J. E. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291, 1978\u20131986 (2004).","journal-title":"JAMA"},{"key":"469_CR237","unstructured":"NIH. Coronavirus disease 2019 (COVID-19) treatment guidelines. NIH https:\/\/www.covid19treatmentguidelines.nih.gov\/ (2020)."},{"key":"469_CR238","unstructured":"CDC. Interim clinical guidance for management of patients with coronavirus disease 2019 (COVID-19). CDC https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-guidance-management-patients.html (2020)."},{"key":"469_CR239","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764","author":"JH Beigel","year":"2020","unstructured":"Beigel, J. H. et al. Remdesivir for the treatment of Covid-19 \u2013 final report. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2007764 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR240","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/jama.2020.4783","volume":"323","author":"C Shen","year":"2020","unstructured":"Shen, C. et al. Treatment of 5 critically Ill patients with COVID-19 with convalescent plasma. JAMA 323, 1582\u20131589 (2020).","journal-title":"JAMA"},{"key":"469_CR241","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","author":"The RECOVERY Collaborative Group","year":"2020","unstructured":"The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19 \u2013 preliminary report. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2021436 (2020).","journal-title":"N. Engl. J. Med."},{"key":"469_CR242","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood.2020006000","volume":"135","author":"JM Connors","year":"2020","unstructured":"Connors, J. M. & Levy, J. H. COVID-19 and its implications for thrombosis and anticoagulation. Blood 135, 2033\u20132040 (2020).","journal-title":"Blood"},{"key":"469_CR243","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli, B. et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J. Am. Coll. Cardiol. 75, 2950\u20132973 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"469_CR244","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.chest.2019.10.043","volume":"157","author":"VV McLaughlin","year":"2020","unstructured":"McLaughlin, V. V. et al. Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents. Chest 157, 955\u2013965 (2020).","journal-title":"Chest"},{"key":"469_CR245","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/CIRCRESAHA.107.165936","volume":"102","author":"E Arehart","year":"2008","unstructured":"Arehart, E. et al. Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition. Circ. Res. 102, 986\u2013993 (2008).","journal-title":"Circ. Res."},{"key":"469_CR246","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fphar.2011.00024","volume":"2","author":"J Stitham","year":"2011","unstructured":"Stitham, J., Midgett, C., Martin, K. A. & Hwa, J. Prostacyclin: an inflammatory paradox. Front. Pharmacol. 2, 24 (2011).","journal-title":"Front. Pharmacol."},{"key":"469_CR247","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/01.CIR.102.20.2460","volume":"102","author":"A Veyradier","year":"2000","unstructured":"Veyradier, A. et al. Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertension. Circulation 102, 2460\u20132462 (2000).","journal-title":"Circulation"},{"key":"469_CR248","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1046\/j.1538-7836.2003.00345.x","volume":"1","author":"G Walford","year":"2003","unstructured":"Walford, G. & Loscalzo, J. Nitric oxide in vascular biology. J. Thromb. Haemost. 1, 2112\u20132118 (2003).","journal-title":"J. Thromb. Haemost."},{"key":"469_CR249","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","volume":"113","author":"U Forstermann","year":"2006","unstructured":"Forstermann, U. & Munzel, T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113, 1708\u20131714 (2006).","journal-title":"Circulation"},{"key":"469_CR250","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.10.20033522","author":"C Lei","year":"2020","unstructured":"Lei, C. et al. Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19. medRxiv https:\/\/doi.org\/10.1101\/2020.03.10.20033522 (2020).","journal-title":"medRxiv"},{"key":"469_CR251","doi-asserted-by":"publisher","first-page":"110051","DOI":"10.1016\/j.mehy.2020.110051","volume":"143","author":"JJ DiNicolantonio","year":"2020","unstructured":"DiNicolantonio, J. J. & Barroso-Aranda, J. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: potential of pentoxifylline and dipyridamole. Med. Hypotheses 143, 110051 (2020).","journal-title":"Med. Hypotheses"},{"key":"469_CR252","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.apsb.2020.04.008","volume":"10","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19. Acta Pharm. Sin. B 10, 1205\u20131215 (2020).","journal-title":"Acta Pharm. Sin. B"},{"key":"469_CR253","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cellsig.2019.05.011","volume":"61","author":"S Yasmeen","year":"2019","unstructured":"Yasmeen, S., Akram, B. H., Hainsworth, A. H. & Kruuse, C. Cyclic nucleotide phosphodiesterases (PDEs) and endothelial function in ischaemic stroke. A review. Cell Signal. 61, 108\u2013119 (2019).","journal-title":"Cell Signal."},{"key":"469_CR254","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04365309?term=NCT04365309&draw=2&rank=1 (2020)."},{"key":"469_CR255","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04363840 (2020)."},{"key":"469_CR256","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04410328 (2020)."},{"key":"469_CR257","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04382755 (2020)."},{"key":"469_CR258","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04288713 (2020)."},{"key":"469_CR259","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04453527 (2020)."},{"key":"469_CR260","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.amjcard.2020.08.004","volume":"134","author":"CS Kow","year":"2020","unstructured":"Kow, C. S. & Hasan, S. S. Meta-analysis of effect of statins in patients with COVID-19. Am. J. Cardiol. 134, 153\u2013155 (2020).","journal-title":"Am. J. Cardiol."},{"key":"469_CR261","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04407273 (2020)."},{"key":"469_CR262","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04472611 (2020)."},{"key":"469_CR263","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04486508 (2020)."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41569-020-00469-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41569-020-00469-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41569-020-00469-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:24:38Z","timestamp":1684607078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-020-00469-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":263,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1038\/s41569-020-00469-1","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/A1ACQN","asserted-by":"object"}]},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"19 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}